Darin Goldman, MD
Retina Specialist · Ft Lauderdale, FLNPI 1861699290
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,629 and has fallen 52.0% since, to $782 in 2025.
Across 86 payments — averaging $70.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Apellis Pharmaceuticals, Inc.$458
- Regeneron$363
- Novartis$322
- Rayner Intraocular Lenses Limited$250
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,95898%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 25 | $1,450 |
| Regeneron Healthcare Solutions, Inc. | 22 | $1,311 |
| Apellis Pharmaceuticals, Inc. | 7 | $458 |
| Regeneron | 4 | $363 |
| Novartis | 4 | $322 |
| Rayner Intraocular Lenses Limited | 2 | $250 |
| Coherus Oncology, Inc. | 4 | $220 |
| Astellas Pharma US Inc | 2 | $151 |
| Alcon | 2 | $144 |
| Bausch & Lomb Americas Inc. | 1 | $125 |
| Omeros Corporation | 1 | $125 |
| Dutch Ophthalmic, USA | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 1 | $122 |
| Biotissue Holdings Inc. | 1 | $120 |
| Mallinckrodt Hospital Products Inc. | 1 | $107 |
| Eyevance Pharmaceuticals LLC | 1 | $107 |
| Spark Therapeutics, Inc. | 1 | $106 |
| Aerie Pharmaceuticals, Inc. | 1 | $105 |
| Dompe US, Inc. | 1 | $103 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $99 |
| Sight Sciences, Inc. | 1 | $90 |
| Sandoz | 1 | $31 |
| Viiv Healthcare Company | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$774
- VABYSMO$404
- EYLEA HD$383
- Lucentis$366
- SUSVIMO$272
- OMIDRIA$250
- Lunsumio$159
- EVA, combined machine$125
- TISSUEBLUE$125
- VYZULTA$125
- RayOne EMV$125
- RayOne Spheric$125
- RayOne Aspheric$125
- INVELTYS$122
- AcrySof IQ PanOptix$122
- Izervay$118
- ACTHAR$107
- Flarex$107
- Cimerli$106
- LUXTURNA$106
How this compares
$6,052 in reported general payments places this provider in the 55th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 121 | $6,067 |
| Difluprednate | 31 | $3,292 |
| Ketorolac Tromethamine | 33 | $1,261 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 95 | $784 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $257 |
| Timolol Maleate | 14 | $115 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Ft Lauderdale
- Eduardo UchiyamaFt Lauderdale$356K
- Mario del CidFt Lauderdale$14K
- Ryan ShieldsFt Lauderdale$10K
- Barry TaneyFt Lauderdale$6K
- Robert LalaneFt Lauderdale$5K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.